Phenotypic similarities in bilateral breast cancer

Breast Cancer Research and Treatment

Volumn 85, Issue 3, 2004, Pages 255-261

  Kollias, J ^a,b   Pinder, S E ^a   Denley, H E ^a   Ellis, I O ^a   Wencyk, P ^a   Bell, J A ^a   Elston, C W ^a   Blamey, R W ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Bilateral; Breast cancer; Histopathology; Immunohistochemistry

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; ENVIRONMENTAL EXPOSURE; FEMALE; HEREDITY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; BREAST TUMOR; GENETICS; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PHENOTYPE; RETROSPECTIVE STUDIES;

EID: 3042620536     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000025421.00599.b7     Document Type: Article

References (37)

1. Robbins GF, Berg JW: Bilateral primary breast cancers. A prospective clinico-pathological study. Cancer 21: 1502-1527, 1968
2. Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG: Second primary cancers of the breast: incidence and risk factors. Br J Cancer 49: 79-85, 1984
3. Chaudary MA, Millis RR, Hoskins EOL, Halder M, Bulbrook RD, Cuzick J, Hayward JL: Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 71: 711-714, 1984
4. Fisher ER, Fisher B, Sass R, Wickerham L: Pathological findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): XI. Bilateral breast cancer. Cancer 54: 3002-3011, 1984
5. Wanebo HJ, Senofsky G, Fechner RE, Kaiser D, Lynn S, Paradies J: Bilateral breast cancer: risk reduction by contralateral biopsy. Ann Surg 201: 667-677, 1985
6. Mueller CB, Ames F: Bilateral breast cancer: frequency and mortality. Can J Surg 21: 459-165, 1978
7. Rochefordiere A de la, Asselain B, Scholl SM, Campana F, Ucla L, Vilcoq JR, Durand JC, Pouillart P, Fourquet A: Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 30(1): 35-41, 1994
8. Chaudary MA, Millis RR, Hoskins EOL, Halder M, Bulbrook RD, Cuzick J, Hayward JL: Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 71: 711-714, 1984
9. Ellis IO, Galea M, Broughton, Locker A, Blamey RW, Elston CW: Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20: 479-489, 1992
10. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991
11. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JFR, Blammey RW, Ellis IO: Assessment of the new proliferative marker MTB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 71: 146-149, 1995
12. Lovekin C, Ellis IO, Locker A, Robertson JFR, Bell J, Nicholson R, Gullick WJ, Elston CW, Blamey RW: C-erB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 63: 439-443, 1991
13. Ellis IO, Bell J, Todd JM, Williams M, Dowle C, Robins RA, Elston CW, Blamey RW, Baldwin RW: Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma. Br J Cancer 56: 295-299, 1987
14. Fliess JL: Statistical Methods for Rates and Proportions. 2nd edn, John Wiley and Sons, New York, NY, 1981
15. Hall JG: Twinning: mechanisms and genetic implications. Curr Opin Genet Dev 6: 343-347, 1996
16. Prior P, Waterhouse JA: Incidence of bilateral tumours in a population series of breast-cancer patients. I. Two approaches to an epidemiological analysis. Br J Cancer 37: 620-634, 1978
17. Weber BL, Heise H, Neifield JP, Cost J: Risk of breast cancer in a population of patients with in situ breast carcinoma. Cancer 47: 2928-2932, 1981
18. McCredie JA, Inch WR, Alderson M: Consecutive primary carcinomas of the breast. Cancer 35: 1472-1477, 1975
19. Del Turco MR, Ciatto S, Prigli G, Borrelli D, Carcangiu ML, Santucci M: Bilateral cancer of the breast. Tumori 68: 155-160, 1982
20. Khafagy MM, Schottenfield D, Robbins GF: Prognosis of the second breast cancer. The role of previous exposure to the first primary. Cancer 596-599, 1975
21. Fisher ER, Fisher B, Sass R, Wickerham L: Pathological findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): XI. Bilateral breast cancer. Cancer 54: 3002-3011, 1984
22. Kollias J, Ellis IO, Elston CW, Blamey RW: Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 25: 1117-1124, 2001
23. Gollamandi SV, Gelman RS, Peiro G, Schneider LJ, Schnitt SJ, Recht A, Silver BJ, Harris JR, Connolly JL: Breast-conserving therapy for stage I-II synchronous bilateral breast cancer. Cancer 79: 1362-1369, 1997
24. Dawson PJ, Maloney T, Gimotty P, Juneau P, Ownby H, Wolman S: Bilateral breast cancer: one disease or two? Breast Cancer Res Treat 19: 233-244, 1991
25. Sterns EE, Fletcher WA: Bilateral cancer of the breast: a review of clinical, histological and immunohistologic characteristics. Surgery 110: 617-622, 1991
26. Idvall I, Mandahl N, Mitelman F, Heim S: Chromosome abnormalities in bilateral breast carcinomas: cytogenetic evaluation of the clonal origin of multiple primary tumours. Cancer 76(2): 250-258, 1995
27. Tsuda H, Hirohashi S: Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res 55: 3395-3398, 1995
28. Lundy J, Mishriki Y, Varma AO, Kufe D, Schuss A: Tumour-associated antigens in bilateral breast cancer. J Surg Oncol 35: 24-29, 1987
29. Gogas J, Markopoulos C, Skandalakis P, Gogas H: Bilateral breast cancer. Am Surg 59(11): 733-735, 1993
30. Hahnel R, Twaddle E: The relationship between oestrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas. Breast Cancer Res Treat 5: 155-163, 1985
31. Holdaway IM, Mason H, Bennett RC, Alexander AI, Hahnel R, Kiang DT: Estrogen receptors in bilateral breast cancer. Cancer 62: 109-113, 1988
32. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451-1467, 1998
33. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group: Anastrazole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359: 2131-2139, 2002
34. Bernstein JL, Thompson WD, Risch N, Holfors TR: The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136: 937-948, 1992
35. Anderson DE: Genetic study of breast cancer: identification of a high risk group. Cancer 34: 1090-1097, 1974
36. Anderson DE, Badzioch MD: Bilaterality in familial breast cancer patients. Cancer 56: 2092-2098, 1985
37. Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Lenoir GM, Serova O, Lynch HT: Hereditary breast cancer - pathobiology, prognosis and BRCA1 and BRCA2 linkage. Cancer 77: 697-709, 1996